Additional Details

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Columbia University Medical Center-New York Presbyterian Hospital
New York, NY 10032